medical treatments went down 0.86 % due to the expenses of CMR increased 0.37% and the separate financial decrease 2.53%. 3. The net income increased 70.30% (Separate financial statement : increased 13.61
treatments went down 9.20 % due to the expenses of CMR decreased 2.34% and the separate financial decrease 2.45%. 3. The net income increased 27.08% (Separate financial statement : increased 20.11 %) due to
income from medical treatments went down 1.62 % due to the expenses of CMR decreased 1.46% and the separate financial decrease 1.52% . 3. The net income increased 79.98% (Separate financial statement
% and the separate financial decrease 1.52% . 3. The net income increased 79.98% (Separate financial statement : decreased 23.16 %) due to the share of profit of associates increased amount Baht 55.49
. Revenue from sales and services decrease from prior year by Baht 6.3 million or 71% due following to: Description 3Q2019 Million Baht 3Q2018 Million Baht Change Million Baht Change (%) Revenue from real
downwards the 2020 GDP forecast in their Monetary Policy Report, saying the economy was likely to contract by 8.1%. Although Thailand has successfully controlled the spread of COVID-19 so far, leading to a
, decrease by Baht 49.4 million or 38.7% from last year due to recognition of non-monetary and non-recurring expenses i.e. share- based payment of Baht 61 million and impairment loss on assets of Baht 13.4
2019 was Baht 16.3 million, a decrease of Baht 118.8 million or 88% from the same period of last year since there were no recognition of non- monetary and non-recurring expenses i.e. share-based payment
2019 was Baht 16.3 million, a decrease of Baht 118.8 million or 88% from the same period of last year since there were no recognition of non- monetary and non-recurring expenses i.e. share-based payment
2Q 2020/21 PERFORMANCE ANALYSIS (YOY) In 2Q 2020/21, MACO recorded an operating revenue of THB 507mn, a decrease of 32.2% YoY. The decline on overall performance was from the prolonged impact of COVID